Mulya.ai
Ticker
HCA
Scenario
Key Inputs
Revenue est.?Analyst
OP margin est.?Analyst
Reinvestment est.?projected
R&D capitalizedNo
Leases factoredNo
Key Assumptions
WACC ?10.1%
ERP ?4.5%
Risk-free rate ?4.1%
Beta (blended) ?1.342
Beta (levered) ?1.829
Terminal OM% ?17.5%
Segment conc. ?51% dominant
Terminal growth ?4.1%
Bond rating ?A · 1.20%
ROIC option ?Opt 4 · 23.6%
Prob of failure ?0.0%
Pipeline validated · 2026-05-17

HCA · HCA Healthcare, Inc.

$471.842026-05-17
Sector: Healthcare; Industry: Medical - Care Facilities; Sub-Industry: Health Care Facilities

Intrinsic Value Range Comparison · Mulya.ai

Bull
$1079
+128.8% vs market
Base · active
$701
+48.6% vs market
Bear
$603
+27.7% vs market
Mulya.ai vs Analyst IV Comparison?
Market $472
Median $525
Bear $603
Base $701
Bull $1079
Market Price $472
Mulya.ai Base $701
Analysts Median $525
Mulya.ai IV range ($603 · $1079)
Analysts Range ($425 · $635)
Fundamentals · historical + forward · base
italics = DCF projection
PeriodRevenueRev Gr ?Ops M% ?Tax Rate ?NOPAT ?
Reinvest ?
FCFF ?WACC% ?PV FCFF ?ROIC ?Inv. Cap ?EPS ?P/E
2021.Q4$58.8B16.5%21.5%$7.6B−$172MM$7.4B9.2%23.3%$32.6B$30.15
2022.Q4$60.2B2.5%15.0%20.3%$7.2B−$1.6B$5.6B9.7%21.4%$34.8B$24.46
2023.Q4$65.0B7.9%14.8%21.0%$7.6B−$2.6B$5.0B9.4%21.1%$37.2B$22.72
2024.Q4$70.6B8.7%14.9%21.9%$8.2B−$1.9B$6.3B9.9%21.6%$38.9B$24.97
2025.Q4$75.6B7.1%15.8%20.9%$9.5B$493MM$10.0B10.0%23.6%$41.3B$29.409.1
italics below = DCF projection · 10yr Rev CAGR: 5.8%
2026.Q4$78.6B+4.0%15.8%20.8%$9.8B−$1.6B$8.3B10.0%$7.5B23.4%$42.9B$42.6511.1
2027.Q4$82.4B+4.8%15.8%20.7%$10.3B−$2.0B$8.3B9.8%$6.9B23.5%$44.9B$44.7410.5
2028.Q4$86.9B+5.5%15.8%20.6%$10.9B−$2.4B$8.5B9.7%$6.4B23.7%$47.3B$47.2510.0
2029.Q4$92.7B+6.6%15.8%20.5%$11.6B−$2.4B$9.3B9.6%$6.4B24.0%$49.7B$50.449.4
2030.Q4$100.4B+8.4%15.8%20.4%$12.6B−$3.4B$9.3B9.4%$5.8B24.6%$53.0B$54.728.6
Term. Yr+$138.6B4.1%17.5%20.0%$19.4B−$3.4B$16.0B8.6%$145.7B23.6%
Active scenario IV: $701 (+48.6% vs market)